|
End-of-day quote
Shanghai S.E.
30/09/2026
|
5-day change | 1st Jan Change | ||
| 9.430 CNY | +1.07% |
|
-2.68% | -12.77% |
| Market Cap | 5.47B 815M 718M 680M 614M 1.16B 78.17B 1.17B 8.14B 3.13B 39.96B 3.06B 2.99B 128B | P/E 2024 |
20.4x | P/E 2025 | 46.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.97B 740M 652M 618M 558M 1.05B 70.98B 1.06B 7.39B 2.84B 36.28B 2.78B 2.72B 116B | EV / Sales 2024 |
0.41x | EV / Sales 2025 | 0.56x |
| Free-Float |
24.73% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.07% | ||
| 1 week | -2.68% | ||
| 1 month | -6.73% | ||
| 3 months | +21.52% | ||
| 6 months | -7.46% | ||
| Current year | -12.77% |
| 1 week | 9.28 | 9.73 | |
| 1 month | 9.17 | 10.53 | |
| Current year | 7.54 | 13.16 | |
| 1 year | 7.54 | 18.13 | |
| 3 years | 4.96 | 18.13 | |
| 5 years | 4.96 | 18.13 | |
| 10 years | 4.88 | 18.13 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei Dong Zhu
CEO | Chief Executive Officer | 57 | 26/09/2016 |
Ping Guan
DFI | Director of Finance/CFO | 54 | 07/04/2022 |
Rui Qu
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Dong Zhu
CHM | Chairman | 57 | 15/12/2023 |
Shi Wei Yin
BRD | Director/Board Member | 51 | 26/12/2023 |
Dan Guo
BRD | Director/Board Member | 56 | 26/12/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.07% | -2.68% | +19.52% | +19.97% | 815M | ||
| -0.66% | +0.53% | +51.65% | +115.42% | 1,031B | ||
| -0.58% | -1.65% | +42.78% | +69.98% | 638B | ||
| -0.28% | -1.32% | +12.98% | +75.49% | 462B | ||
| -0.39% | -1.87% | +73.13% | +41.15% | 359B | ||
| +0.40% | -3.41% | +24.34% | +41.50% | 335B | ||
| -0.88% | -0.10% | +14.25% | +27.28% | 273B | ||
| -0.78% | -2.06% | -2.34% | +10.91% | 253B | ||
| -0.72% | +3.80% | +49.37% | +56.84% | 228B | ||
| -0.37% | -1.53% | +34.28% | +98.89% | 185B | ||
| Average | -0.26% | -0.60% | +31.99% | +55.74% | 376.47B | |
| Weighted average by Cap. | -0.41% | -0.35% | +37.67% | +71.37% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10.05B 1.5B 1.32B 1.25B 1.13B 2.13B 144B 2.15B 14.95B 5.75B 73.43B 5.62B 5.5B 235B | 10.38B 1.55B 1.36B 1.29B 1.17B 2.2B 148B 2.22B 15.45B 5.94B 75.84B 5.81B 5.68B 243B |
| Net income | 213M 31.79M 28M 26.53M 23.95M 45.14M 3.05B 45.72M 317M 122M 1.56B 119M 117M 5B | 134M 19.95M 17.57M 16.65M 15.03M 28.33M 1.91B 28.69M 199M 76.65M 978M 74.92M 73.29M 3.14B |
| Net Debt | -200M -29.77M -26.21M -24.84M -22.42M -42.26M -2.85B -42.81M -297M -114M -1.46B -112M -109M -4.68B | -503M -74.99M -66.04M -62.57M -56.49M -106M -7.19B -108M -749M -288M -3.68B -282M -275M -11.79B |
Employees
2,735
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/09/26 | CN¥9.430 | +1.07% | 6,904,682 |
| 29/09/26 | CN¥9.330 | -0.74% | 5,903,495 |
| 28/09/26 | CN¥9.400 | -2.29% | 8,239,978 |
| 24/09/26 | CN¥9.620 | -0.72% | 10,896,300 |
| 23/09/26 | CN¥9.690 | -4.06% | 11,967,700 |
- Stock Market
- Stocks
- 600829 Stock
Select your edition
All financial news and data tailored to specific country editions
















